-
Lonza Collaborates with Takeda to Bring Cancer Treatment to Patients
americanpharmaceuticalreview
January 14, 2019
Lonza announced another milestone in its multiproduct partnership with Takeda. Takeda Pharmaceutical announced in November 2018 that ....
-
Lilly Announces Agreement to Acquire Loxo Oncology
americanpharmaceuticalreview
January 08, 2019
Eli Lilly and Company and Loxo Oncology announced a definitive agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash, or approximately $8.0 billion ......
-
Black Diamond debuts with $20M, mission to drug unexplored oncogenes
fiercebiotech
December 27, 2018
Versant Ventures is unveiling Black Diamond Therapeutics, a biotech developing cancer treatments that target an “undrugged and unexplored” group of oncogenes....
-
Bellicum reports first data on ‘controllable’ CAR-T
fiercebiotech
December 26, 2018
Bellicum Pharma has the first data on BPX-601, its first CAR-T with a built-in activation switch to boost its effects, and says initial results show signs of biologic activity.....
-
Younger Breast Cancer Survivors Suffer More Bone Loss From Treatment
drugs
December 12, 2018
Younger breast cancer survivors are at increased risk for osteoporosis -- weak, brittle bones -- due to breast cancer treatments, new study finds.....
-
When good macrophages go bad
worldpharmanews
December 03, 2018
Researchers at Children's Hospital Los Angeles reveal a mechanism by which some cancers trick healthy cells into protecting tumors.
-
NHS announces groundbreaking personalised child cancer treatment
europeanpharmaceuticalreview
September 06, 2018
The NHS has announced a groundbreaking new treatment, CAR-T, for children with leukaemia…
-
NeoTherma picks up $6M to test adjunct pancreatic cancer treatment
fiercebiotech
August 20, 2018
NeoTherma Oncology raised $6 million to bring its thermal device for cancer treatment into human testing. Its first stop? Pancreatic cancer.
-
Gut-liver connection uncovers new avenues for cancer treatment
fiercebiotech
May 29, 2018
Studies have suggested there are links between the gut microbiome, the immune response and cancer, but the role of bacteria in the development of liver cancer is not well understood.
-
Adaptimmune Sees Positive Early Results in Cancer Treatment
biospace
March 19, 2018
Adaptimmune Ltd. shares rose late Thursday